Literature DB >> 15240507

Histone H4 histidine kinase displays the expression pattern of a liver oncodevelopmental marker.

Eiling Tan1, Paul G Besant, Xin Lin Zu, Christoph W Turck, Marie A Bogoyevitch, Seng Gee Lim, Paul V Attwood, George C Yeoh.   

Abstract

Protein phosphorylation is a vital process in the regulation of mammalian cell division and the protein kinases that catalyze the phosphorylation of proteins on serine, threonine and tyrosine residues have been well characterized. In contrast, little is known about the kinases involved in protein histidine phosphorylation, which have been described in various mammalian cells that are highly proliferative. Histone H4 histidine kinase (HHK) activity is highly active in regenerating rat liver. Using a novel and specific assay, we demonstrate that it is active in human fetal liver, essentially absent in adult liver and highly expressed in liver tumours. 'Normal' liver surrounding the HCC contains low to undetectable levels of HHK. In a rodent model of chronic liver injury that leads to HCC, its activity is induced. Two lines of evidence suggest that liver progenitor (oval) cells, which populate the liver at early stages following induction of liver damage are responsible for the increased activity. Purified oval cells, as well as cell lines established from primary cultures of oval cells express high levels of HHK. We propose that the pattern of expression of histone H4 histidine kinase activity justifies its classification as an oncodevelopmental marker and suggest it may be useful as a diagnostic marker for hepatocellular carcinoma as well for identifying preneoplastic lesions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240507     DOI: 10.1093/carcin/bgh222

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  13 in total

Review 1.  Chasing phosphohistidine, an elusive sibling in the phosphoamino acid family.

Authors:  Jung-Min Kee; Tom W Muir
Journal:  ACS Chem Biol       Date:  2011-12-09       Impact factor: 5.100

2.  Development of stable phosphohistidine analogues.

Authors:  Jung-Min Kee; Bryeanna Villani; Laura R Carpenter; Tom W Muir
Journal:  J Am Chem Soc       Date:  2010-10-20       Impact factor: 15.419

Review 3.  Detection and analysis of protein histidine phosphorylation.

Authors:  Paul G Besant; Paul V Attwood
Journal:  Mol Cell Biochem       Date:  2009-04-23       Impact factor: 3.396

4.  Post-translational modifications: Panning for phosphohistidine.

Authors:  Matthew J Piggott; Paul V Attwood
Journal:  Nat Chem Biol       Date:  2013-05-26       Impact factor: 15.040

Review 5.  Advances in development of new tools for the study of phosphohistidine.

Authors:  Mehul V Makwana; Richmond Muimo; Richard Fw Jackson
Journal:  Lab Invest       Date:  2017-12-04       Impact factor: 5.662

Review 6.  pHisphorylation: the emergence of histidine phosphorylation as a reversible regulatory modification.

Authors:  Stephen Rush Fuhs; Tony Hunter
Journal:  Curr Opin Cell Biol       Date:  2017-01-25       Impact factor: 8.382

Review 7.  The histidine phosphatase LHPP: an emerging player in cancer.

Authors:  Fahong Wu; Hanwei Ma; Xiaoli Wang; Hangzhi Wei; Wei Zhang; Youcheng Zhang
Journal:  Cell Cycle       Date:  2022-03-03       Impact factor: 5.173

Review 8.  Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives.

Authors:  Federico Andreoli; Arménio Jorge Moura Barbosa; Marco Daniele Parenti; Alberto Del Rio
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.310

9.  Hydrogen-deuterium exchange in imidazole as a tool for studying histidine phosphorylation.

Authors:  Małgorzata Cebo; Martyna Kielmas; Justyna Adamczyk; Marek Cebrat; Zbigniew Szewczuk; Piotr Stefanowicz
Journal:  Anal Bioanal Chem       Date:  2014-10-30       Impact factor: 4.142

Review 10.  Alterations in reversible protein histidine phosphorylation as intracellular signals in cardiovascular disease.

Authors:  Thomas Wieland; Paul V Attwood
Journal:  Front Pharmacol       Date:  2015-08-21       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.